BBC producer Isabel Kimbrey was diagnosed with Tourette’s syndrome at the age of 7, and shared how she wanted to open up the conversation about Tourette's in "the most realistic way".

That’s exactly what happened to Georgia when she first developed Tourette’s Syndrome. Image caption, Georgia, right, was in the middle of her mock GCSE exams when she showed signs of Tourette ...

By blocking dopamine-1 receptors, ecopipam is expected to reduce the repetitive and compulsive behaviors seen in Tourette syndrome.

Relmada Therapeutics has announced the acquisition of Sepranolone, a Phase 2b ready neurosteroid developed for treating Tourette syndrome (TS) and related compulsive disorders, from Asarina Pharma ...

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the stage for the Chicago-based firm to submit the drug candidate for ...